India markets closed
  • BSE SENSEX

    50,193.33
    +612.60 (+1.24%)
     
  • Nifty 50

    15,108.10
    +184.95 (+1.24%)
     
  • Dow

    34,377.85
    +50.06 (+0.15%)
     
  • Nasdaq

    13,414.93
    +35.88 (+0.27%)
     
  • BTC-INR

    3,204,059.50
    -84,292.00 (-2.56%)
     
  • CMC Crypto 200

    1,224.19
    -28.95 (-2.31%)
     
  • Hang Seng

    28,593.81
    +399.72 (+1.42%)
     
  • Nikkei

    28,406.84
    +582.01 (+2.09%)
     
  • EUR/INR

    89.2759
    +0.1166 (+0.13%)
     
  • GBP/INR

    103.7589
    +0.1040 (+0.10%)
     
  • AED/INR

    19.8420
    -0.0690 (-0.35%)
     
  • INR/JPY

    1.4877
    +0.0011 (+0.07%)
     
  • SGD/INR

    54.9480
    +0.0290 (+0.05%)
     

AbCellera to Report First Quarter 2021 Financial Results on May 13, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
  • Oops!
    Something went wrong.
    Please try again later.

AbCellera (Nasdaq: ABCL) will announce its first-quarter 2021 financial results on Thursday, May 13, 2021 and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

A live webcast will be available on AbCellera’s Investor Relations website at: https://investors.abcellera.com/. Replay of the webcast will be available through the same link following the conference call.

About AbCellera

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. To learn more, please visit www.abcellera.com.

Source: AbCellera Biologics Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210421005994/en/

Contacts

Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774
Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116